Navigation Links
Spherix Announces Post-Hoc Analysis of Phase 3 Trial With D-Tagatose in Diabetes
Date:12/2/2010

acid transport mediated by GLUT-4. This negative feedback mechanism may protect adipocytes from lipid overload and restrict further expansion of adipose tissue, which leads to obesity and metabolic complications. However, when the negative feedback mechanism is activated, fatty acid transport in the enlarged cells is inhibited, and the enlarged cells are in a sense no longer available to participate in glucose homeostasis.

The association between high carbohydrate diet and hypertriglyceridemia is stronger for those who are overweight (BMI >28). Insulin resistance is more common among the overweight and the obese (BMI >30) and is suspected to be a result of carbohydrate-induced hypertriglyceridemia. [Parks, 2002]  In the adipocyte, glucose is transported into the cell mediated by the glucose transporter type-4 (GLUT-4). Glucose can be converted to alpha-glycerol phosphate, the main source of the glycerol backbone of triglycerides. These triglycerides, during adipocyte dysfunction, are broken down and released back into circulation resulting in free fatty acid overload at skeletal muscle and insulin resistance [Guilherme, 2008].

It is hypothesized that reducing glucose transport into the adipocyte could decrease triglyceride deposition, thus making less triglyceride available for release during a metabolically dys-regulated state. D-tagatose shares common metabolic pathways with other sugars and it is possible that it may compete with glucose for transport into the adipocytes via the GLUT-4 transporter. Once in the cell, it may interfere with lipolysis of the formed triglycerides. If this occurred, D-tagatose would be most effective in those patients whose diabetes control was impaired (resulting in high HbA1c levels) to a larger extent by metabolic dysregulation of the adipocytes.

As a result of this analysis of the Phase 3 clinical trial results, Biospherics is currently designing new studies in cell culture, animal models and
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. Spherix D-tagatose to be Supplied by Inalco SpA
4. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
5. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
6. Spherix Elects New Independent Director, and Elects Chairman of the Board
7. Spherix Reports First Quarter 2009 Earnings
8. Spherix Announces Positive Phase 2 Study Results
9. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
10. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
11. Spherix Reports Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
(Date:9/19/2014)... 2014 According to market ... Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, ... Rotary) & Geography - Global Trends & Forecast ... the lyophilization market on the basis of various ... of the market size of each of these ...
(Date:9/19/2014)... SAN DIEGO , Sept. 19, 2014 /PRNewswire/ ... industry leader in bioactive lipid-targeted therapeutics, announced today ... sell 3,605,042 registered shares of common stock and ... The combined purchase price for one registered share ... purchase one unregistered share of common stock will ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... N.J., April 28, 2011 Savient Pharmaceuticals, Inc. (Nasdaq: ... presented at the European League Against Rheumatism (EULAR) 2011 Annual ... 28 in London, United Kingdom, and will feature the abstracts ... The first scheduled oral presentation and the poster session will ...
... April 28, 2011 Pharmasset, Inc. (Nasdaq: VRUS ... Healthcare Conference being held May 2 to 4, 2011 at ... America Merrill Lynch Healthcare Conference being held May 10 to ... Schaefer Price, Pharmasset,s President and Chief Executive Officer, will provide ...
Cached Medicine Technology:Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress 2Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3
(Date:9/19/2014)... disease, is caused by the bacterium Mycobacterium ... is a legal obligation to report the disease. ... and wasting among affected animals. The disease can ... animals produce less milk, exhibit fertility problems and ... udder inflammation. , To date there has ...
(Date:9/19/2014)... Lifeinsuranceprices.info has released a new blog ... insurance quotes online. , Clients who smoke or ... life insurance quotes from multiple providers on a single ... , Smoking will always influence life insurance prices, ... 50% more for life coverage and if they have ...
(Date:9/19/2014)... The Canton Group, Baltimore’s leading web development ... for the Xaverian Brothers. The new site aligns the Catholic ... edify one another through a life of Gospel witness lived ... manifest God’s care and compassionate love to the people of ... using a responsive web design, which allows users to easily ...
(Date:9/19/2014)... September 19, 2014 2014 Market ... a professional and in-depth research report on Kinesio ... including its definition, classification, application, and industry chain ... covers the international market analysis, including China’s domestic ... macroeconomic environment & economic situation analysis. The report ...
(Date:9/19/2014)... Outsourcing services provider Profit By RPO has ... conglomerate to provide HR outsourcing services in India. , " ... partner and will act as a talent acquisition and transformation ... 120 personnel across 3 locations in India in the next ... is a significant win for us and we are delighted ...
Breaking Medicine News(10 mins):Health News:Lymphatic fluid used for first time to detect bovine paratuberculosis 2Health News:Smokers Can Compare Term Life Insurance Quotes At Lifeinsuranceprices.info! 2Health News:Xaverian Brothers Partner with The Canton Group to Launch New Website 2Health News:Kinesio Tape Industry Analysis for North America, Europe, Asia & ROW Key Company Market Status Now at LifeScienceIndustryResearch.com 2Health News:Kinesio Tape Industry Analysis for North America, Europe, Asia & ROW Key Company Market Status Now at LifeScienceIndustryResearch.com 3Health News:Profit By RPO Bags huge RPO contract from US-based Implementation Partner 2
... Year, LIVINGSTON, N.J., Dec. 7 MM2 ... its wholly-owned subsidiary,Genotec Nutritionals, Inc., a New York ... distribution of its branded products and,through custom formulations ... strategic venture to manufacture sofgel capsules in Zhongsan,City, ...
... heart disease, ... Gary Stanton., MELBOURNE, Fla., Dec. 7 Heart Savior, (http://www.heartsavior.com ... one Natural product. Lowering unhealthy cholesterol levels is a good,start, but ... in the arteries and the heart muscle itself. The formulators of,Heart ...
... Conn., Dec. 7 Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ... (PNH), as well as to Soliris(R),(eculizumab), a treatment for ... Society of Hematology Meeting, December 8 - 11 in ... a poster session on red,cell regulation and disorders of ...
... Dec. 6 Inverness Medical,Innovations, Inc. (Amex: ... rapid,diagnostic products for the consumer and professional markets, ... RBC Capital Markets Healthcare,Conference being held December 12, ... Ron Zwanziger, Chief Executive Officer, and Jon Russell, ...
... Effort is part of the ,Holidays at Mariners Inn - ... Friday, December 7, 2007 at 5:30 p.m. ,These men ... Dec. 6 Homeless men from the,Mariners Inn shelter and ... needy families this holiday season. The men will kick off,their ...
... The American Dietetic,Association welcomes and supports changes announced ... to the nation,s Special Supplemental,Nutrition Program for Women, ... the foods included in the WIC program more ... young children., "These changes are the most ...
Cached Medicine News:Health News:MM2 Group Establishes New Venture for Sofgel Manufacture in China 2Health News:MM2 Group Establishes New Venture for Sofgel Manufacture in China 3Health News:New Health Corp. Introduces Heart Savior(TM), the Ultimate Natural Heart Health Product 2Health News:Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting 2Health News:Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007 2Health News:Detroit Homeless Men Adopt Local Families for Christmas 2Health News:American Dietetic Association Supports USDA's New WIC Food Packages 2
Malaria Pf. Assay Range...
An immunochromatographic rapid test for the detection of Plasmodium falciparum in whole blood....
... Uni-Gold™ Pf Malaria Test is a ... presence of Plasmodium falciparum ... an antigen-capture assay detecting presence of ... protein II (PfHRP- II), which is ...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: